Skip to main content

Table 1 Percentage inhibition of BRAFwt after treatment with the synthesized 1-substituted 5,6-dichlorobenzimidazoles 10a–p at 10 µM

From: Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations

Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us